Reaction to Draft NICE Medical Cannabis Guidelines
Clinicians at Sapphire Medical Clinic, the UK’s first clinic offering consultations for all conditions believed to benefit from medical cannabis have welcomed the draft NICE guidelines on the prescribing of medical cannabis published today. The guidelines cover intractable nausea and vomiting as a result of chemotherapy, chronic pain, spasticity, and severe treatment-resistant epilepsy. The development […]
New guidelines published 8th August 2019
When medical cannabis was rescheduled last November the Secretary of State for Health and Social Care announced that NICE were to produce long-term guidelines for cannabis-based medicinal products. Sapphire Medical Clinic is a registered stakeholder in this process. You can read the guidelines here: The National Institute of Care Excellence draft guidelines for cannabis-based medicinal […]